Cargando…

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis

Objective: To test the feasibility of conducting a full-scale project evaluating the potential value of the phosphorylated neurofilament H (pNF-H) and several cytokines as disability markers in relapsing-remitting multiple sclerosis (RRMS). Methods: Twenty-four patients with 5-year RRMS evolution an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrera, María Inés, Kölliker-Frers, Rodolfo Alberto, Otero-Losada, Matilde, Perez Lloret, Santiago, Filippo, Macarena, Tau, Julia, Capani, Francisco, Villa, Andrés M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794405/ https://www.ncbi.nlm.nih.gov/pubmed/31649604 http://dx.doi.org/10.3389/fneur.2019.01046

Ejemplares similares

Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis
por: Kölliker Frers, Rodolfo A., et al.
Publicado: (2022)

Synaptoprotection in Perinatal Asphyxia: An Experimental Approach
por: Herrera, María Inés, et al.
Publicado: (2020)

Interleukin-1 Links Autoimmune and Autoinflammatory Pathophysiology in Mixed-Pattern Psoriasis
por: Kölliker Frers, Rodolfo, et al.
Publicado: (2021)

Could Perinatal Asphyxia Induce a Synaptopathy? New Highlights from an Experimental Model
por: Herrera, María Inés, et al.
Publicado: (2017)

Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease
por: Kölliker-Frers, Rodolfo, et al.
Publicado: (2021)

Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis
por: Porta, Sabrina, et al.
Publicado: (2021)

Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Corrigendum: Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors
por: Kolliker Frers, Rodolfo A., et al.
Publicado: (2018)

Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration
por: Herrera, María I., et al.
Publicado: (2016)

Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats
por: Herrera, Maria I., et al.
Publicado: (2022)

Corrigendum: Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats
por: Herrera, Maria I., et al.
Publicado: (2022)

Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia
por: Udovin, Lucas D., et al.
Publicado: (2020)

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2022)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Neurofilament light chain predicts disease activity in relapsing-remitting MS
por: Varhaug, Kristin N., et al.
Publicado: (2017)

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson's Disease Animal Models from a Molecular Signaling Perspective
por: Udovin, Lucas, et al.
Publicado: (2020)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Serum neurofilament light chain in relapsing-remitting MS: Unchaining disease activity prediction?
por: Marrie, Ruth Ann
Publicado: (2017)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective
por: Bordet, Sofía, et al.
Publicado: (2023)

Neuronal Damage Induced by Perinatal Asphyxia Is Attenuated by Postinjury Glutaredoxin-2 Administration
por: Romero, Juan Ignacio, et al.
Publicado: (2017)

The Genetic Basis of Probable REM Sleep Behavior Disorder in Parkinson’s Disease
por: Perez-Lloret, Santiago, et al.
Publicado: (2023)

Hippocampal Dendritic Spines Modifications Induced by Perinatal Asphyxia
por: Saraceno, G. E., et al.
Publicado: (2012)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing–remitting MS
por: Kuhle, Jens, et al.
Publicado: (2021)

Serum Neurofilaments and OCT Metrics Predict EDSS-Plus Score Progression in Early Relapse-Remitting Multiple Sclerosis
por: Tiu, Vlad Eugen, et al.
Publicado: (2023)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients
por: Giovannoni, Gavin, et al.
Publicado: (2016)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene
por: Kobiec, Tamara, et al.
Publicado: (2021)

Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study
por: Chevalier, Guenson, et al.
Publicado: (2023)

Editorial: Neuroprotection in Synaptic Signalling During Neurological Disorders
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab
por: Johnsson, Magnus, et al.
Publicado: (2022)

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic
por: Otero-Losada, Matilde, et al.
Publicado: (2020)

Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis
por: Cadavid, Diego, et al.
Publicado: (2013)

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
por: Migliore, S., et al.
Publicado: (2017)

Editorial: Neurological comorbidity in metabolic syndrome
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments
por: Ackerley, Steven, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_tetdf41e37p6dtjibbvackc3is